Ulcerative Colitis

Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries.

NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation.

The company has developed its nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.

Acticoat(TM) is a trademark of Smith & Nephew plc SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

Some of the statements above may constitute forward-looking statements within the meaning of securities legislation in the United States and Canada.

In particular, the statement regarding the timing of the results of our Phase 2 clinical trial may be a forward-looking statement for purposes of the U.S.

and Canada securities laws or otherwise.

Clinical trials may be suspended or terminated at any time due to the actions of the FDA, other regulatory authorities, our collaborators, or due to our own actions.

Our clinical trial could be delayed or prevented by several factors, including: delays in identifying and reaching agreement on ac...

Read more...